• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TGF-β 信号通路调控 表达并促进前列腺癌细胞干性。

TGF-β signaling regulates expression and promotes prostate cancer cell stemness.

机构信息

Tongji University Cancer Center, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.

School of Basic Medical Science, Ningxia Medical University, Yinchuan 75004, Ningxia, China.

出版信息

Aging (Albany NY). 2020 May 1;12(9):7747-7760. doi: 10.18632/aging.103085.

DOI:10.18632/aging.103085
PMID:32364525
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7244043/
Abstract

SPOP, a substrate binding adaptor of E3 ubiquitin ligase Cullin3, is frequently mutated in human prostate cancer (PCa). However, whether and how SPOP is regulated at transcriptional level in PCa remain unclear. Here, we report that is down-regulated in PCa stem-like cells (CSCs) and tissues. Our study reveals that SPOP expression is repressed by TGF-β / SMAD signaling axis in PCa CSCs. promoter contains SMAD-binding elements (SBEs), which can interact with SMAD3. Moreover, TGF-β signaling inhibitor SB431542 promotes the SPOP expression and abrogates PCa stemness. Clinically, SPOP expression is downregulated in PCa patients, which is significantly related to a poor prognosis and lower survival rate. Thus, our findings uncover a mechanism of how SPOP expression is mediated in PCa CSCs via TGF-β/ SMAD3 signaling.

摘要

SPOP 是 Cullin3 E3 泛素连接酶的底物结合适配器,在人类前列腺癌(PCa)中经常发生突变。然而,SPOP 是否以及如何在转录水平上在 PCa 中受到调节尚不清楚。在这里,我们报告 在 PCa 干细胞样细胞(CSCs)和组织中下调。我们的研究表明,SPOP 的表达受 PCa CSCs 中 TGF-β/SMAD 信号轴的抑制。 启动子含有 SMAD 结合元件(SBEs),可与 SMAD3 相互作用。此外,TGF-β 信号抑制剂 SB431542 促进 SPOP 的表达并消除 PCa 干性。临床上,SPOP 在前列腺癌患者中表达下调,与预后不良和生存率降低显著相关。因此,我们的研究结果揭示了 TGF-β/SMAD3 信号如何介导 PCa CSCs 中 SPOP 表达的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/7244043/660d8b3d46cf/aging-12-103085-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/7244043/2c09e8ed8a17/aging-12-103085-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/7244043/eae71c331e63/aging-12-103085-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/7244043/57b790d00ad6/aging-12-103085-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/7244043/660d8b3d46cf/aging-12-103085-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/7244043/2c09e8ed8a17/aging-12-103085-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/7244043/eae71c331e63/aging-12-103085-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/7244043/57b790d00ad6/aging-12-103085-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/7244043/660d8b3d46cf/aging-12-103085-g004.jpg

相似文献

1
TGF-β signaling regulates expression and promotes prostate cancer cell stemness.TGF-β 信号通路调控 表达并促进前列腺癌细胞干性。
Aging (Albany NY). 2020 May 1;12(9):7747-7760. doi: 10.18632/aging.103085.
2
AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness.AMPK 促进 SPOP 介导的 NANOG 降解以调控前列腺癌细胞干性。
Dev Cell. 2019 Feb 11;48(3):345-360.e7. doi: 10.1016/j.devcel.2018.11.033. Epub 2018 Dec 27.
3
Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer.前列腺癌中 SPOP 基因分子改变的临床病理意义。
Eur J Cancer. 2014 Nov;50(17):2994-3002. doi: 10.1016/j.ejca.2014.08.009. Epub 2014 Sep 6.
4
G3BP1 inhibits Cul3 to amplify AR signaling and promote prostate cancer.G3BP1 抑制 Cul3 以放大 AR 信号并促进前列腺癌。
Nat Commun. 2021 Nov 18;12(1):6662. doi: 10.1038/s41467-021-27024-x.
5
ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression.ERK1/2 抑制 Cullin 3/SPOP 介导的 PrLZ 泛素化和降解,从而调节前列腺癌的进展。
Cell Death Differ. 2022 Aug;29(8):1611-1624. doi: 10.1038/s41418-022-00951-y. Epub 2022 Feb 22.
6
SPOP mutation induces DNA methylation via stabilizing GLP/G9a.SPOP 突变通过稳定 GLP/G9a 诱导 DNA 甲基化。
Nat Commun. 2021 Sep 29;12(1):5716. doi: 10.1038/s41467-021-25951-3.
7
SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.SPOP 通过 AKT 通路促进 CDCA5 的降解来调节前列腺癌的进展。
Neoplasia. 2021 Oct;23(10):1037-1047. doi: 10.1016/j.neo.2021.08.002. Epub 2021 Sep 10.
8
Mutated SPOP E3 Ligase Promotes 17βHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression.突变的 SPOP E3 连接酶促进 17βHSD4 蛋白降解,从而推动雄激素生成和前列腺癌进展。
Cancer Res. 2021 Jul 1;81(13):3593-3606. doi: 10.1158/0008-5472.CAN-20-3258. Epub 2021 Mar 24.
9
Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly.前列腺癌相关 SPOP 突变通过上调 Caprin1 依赖性应激颗粒组装增强癌细胞存活和多西紫杉醇耐药性。
Mol Cancer. 2019 Nov 26;18(1):170. doi: 10.1186/s12943-019-1096-x.
10
Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer.SPOP 突变型前列腺癌中 INF2 介导的线粒体裂变失调
PLoS Genet. 2017 Apr 27;13(4):e1006748. doi: 10.1371/journal.pgen.1006748. eCollection 2017 Apr.

引用本文的文献

1
TLL1 knockdown attenuates prostate cancer progression by enhancing antitumor immunity.TLL1基因敲低通过增强抗肿瘤免疫来减弱前列腺癌进展。
Oncogene. 2025 Aug 4. doi: 10.1038/s41388-025-03517-7.
2
Widespread activation and critical role of EMT and stemness in the neuroendocrine differentiation of prostate cancer (Review).上皮-间质转化(EMT)和干性在前列腺癌神经内分泌分化中的广泛激活及关键作用(综述)
Oncol Rep. 2025 Sep;54(3). doi: 10.3892/or.2025.8942. Epub 2025 Jul 11.
3
Challenges and opportunities for the diverse substrates of SPOP E3 ubiquitin ligase in cancer.

本文引用的文献

1
SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG.SPOP 通过促进 NANOG 的降解来抑制胰腺癌的进展。
Cell Death Dis. 2019 Oct 17;10(11):794. doi: 10.1038/s41419-019-2017-z.
2
Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells.肿瘤起始干细胞中出现适应性免疫抵抗。
Cell. 2019 May 16;177(5):1172-1186.e14. doi: 10.1016/j.cell.2019.03.025. Epub 2019 Apr 25.
3
SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.SPOP 促进 Nanog 降解以抑制干细胞特性和前列腺癌进展。
SPOP E3泛素连接酶的多种底物在癌症中的挑战与机遇
Theranostics. 2025 May 8;15(13):6111-6145. doi: 10.7150/thno.113356. eCollection 2025.
4
Synergistic targeting strategies for prostate cancer.前列腺癌的协同靶向治疗策略
Nat Rev Urol. 2025 May 20. doi: 10.1038/s41585-025-01042-6.
5
Stemness regulation in prostate cancer: prostate cancer stem cells and targeted therapy.前列腺癌中的干性调控:前列腺癌干细胞与靶向治疗
Ann Med. 2025 Dec;57(1):2442067. doi: 10.1080/07853890.2024.2442067. Epub 2024 Dec 23.
6
SPOP downregulation promotes bladder cancer progression based on cancer cell-macrophage crosstalk via STAT3/CCL2/IL-6 axis and is regulated by VEZF1.SPOP 下调通过 STAT3/CCL2/IL-6 轴促进膀胱癌进展,基于癌细胞-巨噬细胞串扰,并且由 VEZF1 调控。
Theranostics. 2024 Oct 7;14(17):6543-6559. doi: 10.7150/thno.101575. eCollection 2024.
7
Cancer-associated fibroblasts and prostate cancer stem cells: crosstalk mechanisms and implications for disease progression.癌症相关成纤维细胞与前列腺癌干细胞:相互作用机制及其对疾病进展的影响。
Front Cell Dev Biol. 2024 Jul 18;12:1412337. doi: 10.3389/fcell.2024.1412337. eCollection 2024.
8
SPOP regulates the expression profiles and alternative splicing events in human hepatocytes.SPOP调节人类肝细胞中的表达谱和可变剪接事件。
Open Life Sci. 2023 Oct 24;18(1):20220755. doi: 10.1515/biol-2022-0755. eCollection 2023.
9
miR-197-3p Promotes Osteosarcoma Stemness and Chemoresistance by Inhibiting SPOPL.miR-197-3p通过抑制SPOPL促进骨肉瘤干性和化疗耐药性。
J Clin Med. 2023 Feb 1;12(3):1177. doi: 10.3390/jcm12031177.
10
E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities.E3 泛素连接酶在肿瘤干细胞中的作用:肿瘤标志物的关键调节因子和新的治疗机会。
Cell Oncol (Dordr). 2023 Jun;46(3):545-570. doi: 10.1007/s13402-023-00777-x. Epub 2023 Feb 6.
Dev Cell. 2019 Feb 11;48(3):329-344.e5. doi: 10.1016/j.devcel.2018.11.035. Epub 2018 Dec 27.
4
AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness.AMPK 促进 SPOP 介导的 NANOG 降解以调控前列腺癌细胞干性。
Dev Cell. 2019 Feb 11;48(3):345-360.e7. doi: 10.1016/j.devcel.2018.11.033. Epub 2018 Dec 27.
5
Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer.TGF-β 信号驱动的去分化过程增强了人结直肠癌细胞中的干细胞特性。
Oncogene. 2019 Feb;38(6):780-793. doi: 10.1038/s41388-018-0480-0. Epub 2018 Sep 4.
6
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis.TGFβ 驱动基因重建的结肠癌转移中的免疫逃逸。
Nature. 2018 Feb 22;554(7693):538-543. doi: 10.1038/nature25492. Epub 2018 Feb 14.
7
Tumor suppressor SPOP ubiquitinates and degrades EglN2 to compromise growth of prostate cancer cells.肿瘤抑制因子SPOP使EglN2发生泛素化并将其降解,从而抑制前列腺癌细胞的生长。
Cancer Lett. 2017 Apr 1;390:11-20. doi: 10.1016/j.canlet.2017.01.003. Epub 2017 Jan 13.
8
The Molecular Taxonomy of Primary Prostate Cancer.原发性前列腺癌的分子分类学
Cell. 2015 Nov 5;163(4):1011-25. doi: 10.1016/j.cell.2015.10.025.
9
Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation.TMPRSS2-ERG 融合导致的截短 ERG 癌蛋白可抵抗 SPOP 介导的蛋白酶体降解。
Mol Cell. 2015 Sep 17;59(6):904-16. doi: 10.1016/j.molcel.2015.07.025. Epub 2015 Sep 3.
10
SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression.SPOP促进ERG癌蛋白的泛素化和降解以抑制前列腺癌进展。
Mol Cell. 2015 Sep 17;59(6):917-30. doi: 10.1016/j.molcel.2015.07.026. Epub 2015 Sep 3.